Study on Glucose Metabolic Rate in Non-small Cell Lung Cancer Patients with Blood Stasis Syndrome and Non-Blood Stasis Syndrome

Sheng-li He,Jing-cheng Dong,Yi-hui Guan
DOI: https://doi.org/10.3321/j.issn:1003-5370.2004.01.013
2004-01-01
Abstract:OBJECTIVE:To study the difference of glucose metabolic rate in non-small cell lung cancer (NSCLC) patients with blood stasis syndrome and with non-blood stasis syndrome.METHODS:Whole body positron emission tomography (PET) and functional agent 2-[fluorine-18] fluorine-2-deoxy-glucose (18FDG) were used to detect the 18FDG uptake value in regions of interest (ROI) in tumor tissue of patients.RESULTS:In patients with same pathologic type, the maximum and mean standardized uptake value (Max SUV and Mean SUV) were significantly higher in the blood stasis group than those in the non-blood stasis group (P < 0.01); it also showed the same in patients with NSCLC of phase I, II and III (P < 0.05), but the 18FDG uptake rate was obviously enhanced in patients of phase IV (P < 0.01).CONCLUSION:The glucose uptake in NSCLC patients of blood stasis syndrome was higher than that in those with of non-blood stasis syndrome.
What problem does this paper attempt to address?